Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3

15 Sep 2023
0
0

Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3

Anurathapan U, Tim-Aroon T, Zhang W, Sanpote W, Wongrungsri S, Khunin N, Chutipongtanate S, Chirdkiatgumchai V, Ngiwsara L, Jaovisidha S, Khongkraparn A, Pakakasama S, Svasti J, Setchell KDR, Wattanasirichaigoon D, Hongeng S

Pediatr Blood Cancer. 2023;70(3):e30149.

 

Tags

Share this

Related Posts

Hypomethylation of inflammatory genes (COX2, EGR1, and SOCS3) and increased urinary 8-nitroguanine in arsenic-exposed newborns and children. Phookphan, P., Navasumrit, P., Waraprasit, S., Promvijit, J., Chaisatra, K., Ngaotepprutaram, T., &Ruchirawat, M. (2017). Toxicology and Applied Pharmacology, 316, 36-47.
01 Feb 2017
0

Hypomethylation of inflammatory genes (COX2, EGR1, and SOCS3) and increased urinary 8-nitroguanine in arsenic-exposed newborns and children. Phookphan, P., Navasumrit, P., Waraprasit, S., Promvijit, J., Chaisatra, K., Ngaotepprutaram, T., &Ruchirawat, M. (2017). Toxicology and Applied Pharmacology, 316, 36-47.

Hypomethylation of inflammatory genes (COX2, EGR1, and SOCS3) and increased urinary 8-nitroguanine in arsenic-exposed newborns and children. Phookphan, P., Navasumrit, P., Waraprasit, S., Promvijit, J., Chaisatra, K., Ngaotepprutaram, T., &Ruchirawat, M. (2017). Toxicology and Applied Pharmacology, 316, 36-47.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More